BDBM801012 2-((2-((4-(1-((cis)-5-hydroxyadamantan-2-yl)piperidin-4-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)-N,3-dimethylbenzamide ::US12590070, Compound 33

SMILES CNC(=O)c1cccc(C)c1Nc1nc(Nc2ccc(C3CCN([C@H]4C5CC6CC4C[C@@](O)(C6)C5)CC3)cc2OC)ncc1C(F)(F)F

InChI Key InChIKey=VNJBIJXOSIKOHH-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 801012   

TargetProtein-tyrosine kinase 2-beta(Human)
Samjin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 801012BDBM801012(2-((2-((4-(1-((cis)-5-hydroxyadamantan-2-yl)piperi...)
Affinity DataIC50: 101nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/10/2026
Entry Details
US Patent

TargetInsulin receptor(Human)
Samjin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 801012BDBM801012(2-((2-((4-(1-((cis)-5-hydroxyadamantan-2-yl)piperi...)
Affinity DataIC50: 2.05E+3nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/10/2026
Entry Details
US Patent